Clinical Research

Sign up to take part in our clinical research

Be a part of our ongoing research
as we develop new diagnostic products

Sign up

Publications

Clinical Performance of a Lateral Flow SARS-CoV-2 Total Antibody Assay

Detection of immunoglobulin response to COVID-19 vaccination

Pregnancy Testing In Emergency Patients

Qualitative Point-of-Care Human Chorionic Gonadotropin Testing

Funded Research Grants and Contracts

Contract ID: HHSN272201800055C

Contract ID: 75A50120C00156

Clinical Research Projects

NOWDx Syphilis Study

Seeking persons to participate in a clinical study to test the performance of an easy-to-use investigational capillary blood test to aid in the detection of syphilis.

Actively enrolling in: Las Vegas, NV; Tempe, AZ;

Spokane, WA; Miami, FL; West Orange, NJ

QUALIFIED PARTICIPANTS:

• 18-64 years old

• Sexually active

• English or Spanish literate

Duration: < 2 hours

Compensation: $50

NOWDx Strep A Research Study

Seeking persons who have symptoms of strep throat to perform strep tests and donate saliva.

Actively enrolling in: Fayetteville, AR; Pearland, TX;Tampa, FL

QUALIFIED PARTICIPANTS:

• 3-64 years old (parental consent required for participants 3-17)

• Symptomatic for strep throat

• English or Spanish literate

Duration: < 1 hour

Compensation: $50

First Name*

Last Name*

Email *

City*

State*

Zip Code*

Which study are you interested in?*

All participants will receive compensation for their time.

*Required Field

Check out what is making the news

Find out the latest in diagnostics testing.

First and Only In-Home Test for Syphilis Now Available to Consumers through Major Retailers and Public Health: NOWDiagnostics Launches First To Know® Syphilis Test Across the U.S.

November 19, 2024

With syphilis cases on the rise, NOWDx’s over-the-counter test offers rapid, in-home results in minutes and is now available nationwide in thousands of pharmacies, retail, and drugstore locations and on Amazon SPRINGDALE, Ark. – November 19, 2024 – NOWDiagn...

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

October 16, 2024

As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settingsSPRINGDALE, ARK. – October 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of ...

NOWDiagnostics First To Know® Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use

August 16, 2024

First and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announce...